CARPAGNANO, GIOVANNA ELISIANA
 Distribuzione geografica
Continente #
NA - Nord America 4.041
EU - Europa 797
AS - Asia 257
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 5.098
Nazione #
US - Stati Uniti d'America 4.039
SE - Svezia 374
IT - Italia 137
CN - Cina 103
SG - Singapore 100
GB - Regno Unito 79
FR - Francia 49
DE - Germania 41
FI - Finlandia 37
UA - Ucraina 33
VN - Vietnam 29
CZ - Repubblica Ceca 24
IN - India 20
BE - Belgio 7
IE - Irlanda 7
ES - Italia 3
CA - Canada 2
NL - Olanda 2
AU - Australia 1
BN - Brunei Darussalam 1
BR - Brasile 1
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
NO - Norvegia 1
PK - Pakistan 1
PL - Polonia 1
Totale 5.098
Città #
Fairfield 633
Chandler 459
Ashburn 355
Nyköping 313
Woodbridge 313
Seattle 268
Cambridge 241
Houston 216
Wilmington 215
Lawrence 129
Roxbury 112
Des Moines 85
Jacksonville 79
New York 79
Ann Arbor 73
Inglewood 56
San Diego 53
Singapore 53
Paris 40
London 31
Los Angeles 30
Dearborn 29
Dong Ket 29
Princeton 28
Nanjing 21
Helsinki 20
Bari 19
Beijing 17
Boardman 17
Rome 17
Brooklyn 15
Olomouc 13
Turi 12
Brno 11
Norwalk 10
Pune 9
Guangzhou 8
Washington 8
Brussels 7
Dublin 7
Hebei 7
Milan 7
Hounslow 6
Taranto 6
Hyderabad 5
Jiaxing 5
Kilburn 5
Munich 5
Chiswick 4
Falls Church 4
Palermo 4
Reggio Calabria 4
Strasbourg 4
Buffalo 3
Changsha 3
Modugno 3
Prescot 3
Shanghai 3
Shenyang 3
Tianjin 3
Tolentino 3
Zibo 3
Andria 2
Boydton 2
Casalmaiocco 2
Ciudad Real 2
Florence 2
Foggia 2
Grafing 2
Greenwich 2
Huzhou 2
Jinan 2
New Bedfont 2
New Delhi 2
Ravenna 2
Redwood City 2
Wuhan 2
Acquaviva delle Fonti 1
Acton 1
Bandar Seri Begawan 1
Barcelona 1
Bitritto 1
Bore 1
Brisbane 1
Chicago 1
Chongqing 1
Copertino 1
Costa Mesa 1
Dallas 1
Duncan 1
Edinburgh 1
Falkenstein 1
Fleury-les-aubrais 1
Forest City 1
Fuzhou 1
Hangzhou 1
Hefei 1
Islington 1
Jinhua 1
Kansas City 1
Totale 4.276
Nome #
Application of machine learning to predict obstructive sleep apnea syndrome severity 135
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 100
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 99
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease 90
Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity. 85
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 80
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 78
Menopausal asthma: a new biological phenotype? 77
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 74
Predictive equations for CPAP titration in OSAS patients 72
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 72
The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate 70
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 67
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 60
Airway inflammation in patients affected by obstructive sleep apnea syndrome 59
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 57
Aging and airway inflammation 53
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 52
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 52
Diurnal PaCO2 tension in obese women: relationship with sleep disordered breathing 51
Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome 51
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 51
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma 51
A European respiratory society technical standard: Exhaled biomarkers in lung disease 50
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 50
Systemic and airways inflammation in healthy subjects of different ages 49
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 49
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 48
Association between exhaled nitric oxide and nasal polyposis in severe asthma 47
Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome 47
Microparticles in sputum of COPD patients: a potential biomarker of the disease? 47
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 46
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 46
Omalizumab as add-on therapy in a patient with severe asthma and OSA 45
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 45
Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension 44
MicroRNA expression profile during different conditions of hypoxia 44
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects 43
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 43
Characterization of obstructive sleep apnea–hypopnea syndrome (OSA) population by means of cluster analysis 42
Analysis of mitochondrial DNA alteration in new phenotype ACOS 42
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 42
The association between dysphagia and OSA Disfagia e OSA 42
Transthoracic ultrasound sign in severe asthmatic patients: a lack of "gliding sign" mimic pneumothorax 41
Systemic and airways inflammation in healthy subjects and COPD patients of different ages 40
Evidence of lower oxidative stress in the air spaces of patients with reversible COPD 40
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 40
Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation? 40
Values in Elderly People for Exhaled Nitric Oxide Study 39
Viral colonization in exhaled breath condensate of lung cancer patients: Possible role of EBV and CMV 39
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 39
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 38
Dyspnea perception in asthma: Role of airways inflammation, age and emotional status 38
Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy 37
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients 36
HPV in exhaled breath condensate of lung cancer patients 36
Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: How hot is the link? 36
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? 36
Mitochondrial DNA alteration in obstructive sleep apnea 36
How strong is the association between IPF and lung cancer? An answer from airway’s DNA 36
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 36
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 35
HPV-associated lung cancers: An international pooled analysis 35
Effects of omalizumab in severe asthmatics across ages: A real life Italian experience 35
Coexistent Sarcoidosis and Tuberculosis: A Case Report 35
Exhaled Breath Condensate (EBC) for SARS-CoV-2 diagnosis still an open debate 35
Home mechanical ventilation (HMV) decreases mortality in patients affected by amyotrophic lateral sclerosis (ALS 34
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 34
Exhaled breath temperature in NSCLC: Could be a new non-invasive marker? 34
Validation of the Exhaled Breath Temperature Measure: Reference Values in Healthy Subjects 34
VIP: A New Promising Marker for AECOPD-A Fashionable Marker Soon Forgotten? 33
Tissue Doppler Imaging predicts central sleep apnea in patients with chronic heart failure: Data from the Daunia Registry 33
Airways oxidative stress, lung function and cognitive impairment in aging 33
Airway cell patterns in patients suffering from COPD and OSAS (Overlap Syndrome) 33
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 33
"Malattie dell’apparato respiratorio. Pneumologia e chirurgia toracica" 33
Respiratory drive in patients with chronic heart failure and central sleep apnea: Data from the Daunia Heart Failure Registry 32
Exhaled matrix metalloproteinase-9 in lung cancer 32
Wake-up call by breathomics in sleep apnoea 32
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma? 32
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 32
Breathing rhythm variations during wash-in do not influence exhaled volatile organic compound profile analyzed by an electronic nose 32
Neutrophilic airways inflammation in lung cancer: The role of exhaled LTB-4 and IL-8 31
Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients 31
Brittle asthma 31
Microsatellite alterations and cell-free dna analysis: Could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion? 30
Exhaled breath temperature measurement: influence of circadian rhythm 29
Utility of FVC/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension 29
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8 28
New non invasive ventilator strategy applied to COPD patients in acute ventilator failure 28
Exhaled breath condensate is not suitable to detect EGFR somatic mutations 28
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 28
Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis 27
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome 27
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate 26
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects 26
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis 26
Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide 26
Galectin-3 and Neutrophil-to-Lymphocyte ratio are indicative of heart remodelling and disease severity in patients with Obstructive Sleep Apnoea 25
Exhaled breath analysis and sleep 25
Totale 4.432
Categoria #
all - tutte 40.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020631 0 33 9 39 50 58 56 36 46 15 235 54
2020/20211.515 191 26 212 54 125 15 335 102 154 90 151 60
2021/2022858 52 29 3 22 36 112 43 44 104 48 168 197
2022/20231.294 168 192 80 68 113 194 42 133 219 10 43 32
2023/2024682 45 111 49 54 88 163 28 27 17 20 10 70
2024/2025143 108 35 0 0 0 0 0 0 0 0 0 0
Totale 5.431